Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2024, 2025).
Gross margin
€ 1.6 million
▲ 40% vs 2024
Profit
Growing€ 566,855
▲ 85% vs 2024
Debts
Low€ 521,786
▲ 33% vs 2024
ARCHER RESEARCH from Diepenbeek, company number BE0538648522, closed financial year 2025 with a result of € 566,855 after tax. For that financial year ARCHER RESEARCH recorded a gross margin of € 1.6 million and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 306,863 to € 566,855. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
What happened at ARCHER RESEARCH?
What happened at ARCHER RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. Source: NBB ↗
- Lana Gybels became a director. NBB
- FH Impact Management BV stepped down as director. NBB
- Karen Gabriels became a director. NBB
- FH Impact Management BV became a director. NBB
- New establishment in Diepenbeek. KBO
- Start of the company according to the CBE. KBO
In short
From € 231,835 loss in 2021 to € 566,855 profit in 2025.
Paid € 398,572 in corporate taxes since 2021.
Best year ever: 2025, with € 566,855 profit.
On average € 172,100 of value added per employee in 2025.
A new publication or filing at ARCHER RESEARCH? We notify you, reason included.
Follow ARCHER RESEARCHNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ARCHER RESEARCH are Lana Gybels and Karen Gabriels. The shares are held by Duomed Belgium NV (99%) and Hermes Acquireco (1%).
Directors
According to the 2025 annual accounts
Lana Gybels
Director
since 2025
Karen Gabriels
Administrator-manager
since 2024
Director · represented by Frédéric Hoffmann
Also active at: ORTHOSPINE, DUOMED BELGIUM, Duomed Holding Benelux +2 more
since 2024 · until 2025
Shareholders
Hermes Acquireco
1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Agoralaan A box bis
3590 Diepenbeek
Agoralaan A bis
3590 Diepenbeek
Active since 27 August 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
Details
- Company number
- 0538.648.522
- VAT number
- BE 0538.648.522
- Registered office
- Agoralaan A bus bis, 3590 Diepenbeek
- Names & denominations
- ARCHER RESEARCH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 August 2013
- Peppol
- Active · Active since 30 Sept 2025
- Activities · NACE
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Activiteiten van holdings
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Holdings
Schoonheidsverzorging en andere schoonheidsbehandelingen
Activiteiten van medische beeldvorming en medische laboratoria
Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen
+3